We are live on ! Find out more
VERA icon

Vera Therapeutics
VERA

84 hedge funds and large institutions have $538M invested in Vera Therapeutics in 2023 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 38 increasing their positions, 15 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

153% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 15

113% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 8

11% more funds holding

Funds holding: 76 → 84 (+8)

2.44% more ownership

Funds ownership: 86.14% → 88.58% (+2.4%)

12% less capital invested

Capital invested by funds: $612M → $538M (-$73.7M)

29% less funds holding in top 10

Funds holding in top 10: 7 → 5 (-2)

Holders
84
Holders Change
+8
Holders Change %
+10.53%
% of All Funds
1.33%
Holding in Top 10
5
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-28.57%
% of All Funds
0.08%
New
17
Increased
38
Reduced
15
Closed
8
Calls
$364K
Puts
–
Net Calls
+$364K
Net Calls Change
+$2M

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$19.7M
2
WP
Woodline Partners
California
+$13.9M
3
Axa
Axa
France
+$4.65M
4
ACM
Altium Capital Management
New York
+$3.67M
5
BlackRock
BlackRock
New York
+$3.23M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$18.7M
2
CG
Carlyle Group
District of Columbia
-$16.8M
3
Millennium Management
Millennium Management
New York
-$5.36M
4
EP
Eversept Partners
New York
-$4.5M
5
O
OrbiMed
New York
-$4.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
Royal Bank of Canada
76
Royal Bank of Canada
Ontario, Canada
$77K +$38.6K +2,252 +67%
AB
77
Amalgamated Bank
New York
$57K +$14.8K +864 +26%
AIP
78
Ameritas Investment Partners
Nebraska
$45.4K +$8.92K +520 +19%
TRCT
79
Tower Research Capital (TRC)
New York
$32.1K +$7.05K +411 +21%
MLICM
80
Metropolitan Life Insurance Company (MetLife)
New York
$31.1K +$6.59K +384 +20%
Nisa Investment Advisors
81
Nisa Investment Advisors
Missouri
$8.36K +$9.95K +580 +1,933%
LJHT
82
Laurie J. Hall Trustee
$8K +$10.3K +600 New
Russell Investments Group
83
Russell Investments Group
United Kingdom
$6.13K – – –
PNC Financial Services Group
84
PNC Financial Services Group
Pennsylvania
$2.84K – – –
Millennium Management
85
Millennium Management
New York
– -$5.36M -333,689 Closed
BBA
86
Baker Bros. Advisors
New York
– -$2.35M -146,464 Closed
Simplex Trading
87
Simplex Trading
Illinois
– -$1.21M -70,522 Closed
OCA
88
Octagon Capital Advisors
New York
– -$1.12M -70,000 Closed
TI
89
Trexquant Investment
Connecticut
– -$858K -53,474 Closed
IAM
90
Innovis Asset Management
Illinois
– -$348K -21,673 Closed
PP
91
PDT Partners
New York
– -$300K -18,714 Closed
Marshall Wace
92
Marshall Wace
United Kingdom
– -$236K -14,699 Closed
1 2 3
4

VERA Hedge Fund Activity: Q3 2023 in Review

84 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Vera Therapeutics (VERA) for Q3 2023, worth a combined $538M — down 12% from $612M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new VERA positions and 8 closed out — a net gain of 9 holders — while 38 added to existing stakes and 15 trimmed.

The largest buyer was State Street, adding an estimated $19.7M. The largest seller was Fidelity Investments, cutting an estimated $18.7M.

  • 84 institutional investors held Vera Therapeutics (VERA) as of Q3 2023, up from 76 in Q2 2023.
  • Funds reported $538M of Vera Therapeutics stock for Q3 2023, down 12% quarter-over-quarter.
  • 17 funds opened new Vera Therapeutics positions in Q3 2023 and 8 closed out, a net change of +9 holders.
  • The largest Vera Therapeutics buyer in Q3 2023 was State Street, an estimated $19.7M added.
  • The largest Vera Therapeutics seller in Q3 2023 was Fidelity Investments, an estimated $18.7M sold.

Based on aggregated 13F filings for Q3 2023.